Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$32.42
-0.2%
$31.58
$27.07
$40.28
$1.32B1.3218,153 shs237,714 shs
NovoCure Limited stock logo
NVCR
NovoCure
$12.15
-4.6%
$13.20
$10.87
$34.13
$1.42B0.581.27 million shs774,416 shs
RxSight, Inc. stock logo
RXST
RxSight
$9.31
-1.2%
$8.41
$6.32
$57.53
$385.43M1.181.13 million shs733,010 shs
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
$5.80
-7.9%
$6.65
$2.48
$22.42
$1.12BN/A42,610 shs71,574 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.00%+1.45%+10.85%-5.93%-5.90%
NovoCure Limited stock logo
NVCR
NovoCure
0.00%-1.06%+4.83%-30.77%-29.48%
RxSight, Inc. stock logo
RXST
RxSight
0.00%+4.72%+13.26%-34.48%-82.93%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
0.00%-17.14%-14.07%+63.84%+579,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$32.42
-0.2%
$31.58
$27.07
$40.28
$1.32B1.3218,153 shs237,714 shs
NovoCure Limited stock logo
NVCR
NovoCure
$12.15
-4.6%
$13.20
$10.87
$34.13
$1.42B0.581.27 million shs774,416 shs
RxSight, Inc. stock logo
RXST
RxSight
$9.31
-1.2%
$8.41
$6.32
$57.53
$385.43M1.181.13 million shs733,010 shs
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
$5.80
-7.9%
$6.65
$2.48
$22.42
$1.12BN/A42,610 shs71,574 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.00%+1.45%+10.85%-5.93%-5.90%
NovoCure Limited stock logo
NVCR
NovoCure
0.00%-1.06%+4.83%-30.77%-29.48%
RxSight, Inc. stock logo
RXST
RxSight
0.00%+4.72%+13.26%-34.48%-82.93%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
0.00%-17.14%-14.07%+63.84%+579,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.00
Hold$31.50-2.83% Downside
NovoCure Limited stock logo
NVCR
NovoCure
2.57
Moderate Buy$28.79136.92% Upside
RxSight, Inc. stock logo
RXST
RxSight
1.92
Reduce$10.007.41% Upside
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RXST, NVCR, SSII, and CDRE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/8/2025
RxSight, Inc. stock logo
RXST
RxSight
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
8/13/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutralUnderperform$38.00 ➝ $26.00
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$16.00 ➝ $8.00
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$9.00 ➝ $8.00
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$22.00 ➝ $11.00
7/25/2025
NovoCure Limited stock logo
NVCR
NovoCure
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweightEqual Weight$40.00 ➝ $14.50
7/15/2025
RxSight, Inc. stock logo
RXST
RxSight
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweightEqual Weight$20.00 ➝ $9.00
7/10/2025
RxSight, Inc. stock logo
RXST
RxSight
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyHold$24.00 ➝ $9.00
7/9/2025
RxSight, Inc. stock logo
RXST
RxSight
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetUnderperform$18.00 ➝ $9.00
7/9/2025
RxSight, Inc. stock logo
RXST
RxSight
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$18.00 ➝ $10.00
7/9/2025
RxSight, Inc. stock logo
RXST
RxSight
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$17.00 ➝ $9.00
(Data available from 9/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$572.61M2.30$1.41 per share22.94$7.67 per share4.23
NovoCure Limited stock logo
NVCR
NovoCure
$630.16M2.16N/AN/A$3.33 per share3.65
RxSight, Inc. stock logo
RXST
RxSight
$139.93M2.72N/AN/A$6.98 per share1.33
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
$27.62M40.65N/AN/A$0.08 per share72.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$36.13M$0.9434.4923.841.196.65%12.08%5.60%11/5/2025 (Estimated)
NovoCure Limited stock logo
NVCR
NovoCure
-$168.63M-$1.56N/AN/AN/A-27.13%-47.74%-13.79%10/29/2025 (Estimated)
RxSight, Inc. stock logo
RXST
RxSight
-$27.45M-$0.80N/AN/AN/A-21.93%-11.56%-10.31%11/6/2025 (Estimated)
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
-$19.15MN/A0.00N/A-40.20%-40.41%-20.80%N/A

Latest RXST, NVCR, SSII, and CDRE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Guidance Update
RxSight, Inc. stock logo
RXST
RxSight
-$0.04-$0.08-$0.04-$0.29$39.78 million$33.64 million
8/5/2025Q2 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.25$0.30+$0.05$0.30$153.23 million$157.11 million
7/24/2025Q2 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.39-$0.36+$0.03-$0.36$153.87 million$158.80 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.17%N/A40.43%2 Years
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
RxSight, Inc. stock logo
RXST
RxSight
N/AN/AN/AN/AN/A
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/AN/AN/AN/AN/A

Latest RXST, NVCR, SSII, and CDRE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.16%8/1/20258/1/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.90
3.59
2.56
NovoCure Limited stock logo
NVCR
NovoCure
0.28
1.45
1.39
RxSight, Inc. stock logo
RXST
RxSight
N/A
13.93
12.70
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A
2.59
1.66

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
RxSight, Inc. stock logo
RXST
RxSight
78.78%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
31.50%
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
RxSight, Inc. stock logo
RXST
RxSight
9.57%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,28440.66 million27.86 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,488111.80 million105.63 millionOptionable
RxSight, Inc. stock logo
RXST
RxSight
22040.92 million37.00 millionOptionable
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
4193.59 millionN/AN/A

Recent News About These Companies

Ss Innovations (SSII) Q2 Revenue Up 122%
SS Innovations Reports Second Quarter 2025 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cadre stock logo

Cadre NYSE:CDRE

$32.42 -0.07 (-0.22%)
Closing price 09/12/2025 03:59 PM Eastern
Extended Trading
$32.48 +0.07 (+0.21%)
As of 09/12/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$12.15 -0.58 (-4.56%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$12.22 +0.07 (+0.62%)
As of 09/12/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

RxSight stock logo

RxSight NASDAQ:RXST

$9.31 -0.11 (-1.17%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$9.28 -0.03 (-0.32%)
As of 09/12/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

SS Innovations International stock logo

SS Innovations International NASDAQ:SSII

$5.80 -0.50 (-7.94%)
As of 09/12/2025 04:00 PM Eastern

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.